Eli Lilly
Metabolic breakthroughs that work
Indianapolis, Indiana, USA
Eli Lilly and Company is a global healthcare company with a rich history of pharmaceutical innovation, focused on discovering, developing, manufacturing, and selling innovative pharmaceutical products. They specialize in therapeutic areas with unmet medical needs, leveraging advanced technologies like AI in drug discovery and manufacturing, and expanding distribution through platforms like LillyDirect.
How We Help
Problem Statement
Eli Lilly aims to solve significant unmet medical needs by discovering, developing, and providing innovative pharmaceutical products to improve patient health outcomes.
Core Technology
Biotechnology, chemistry, genetic medicine, Artificial Intelligence (AI) and machine learning in drug discovery and optimization, supercomputers for AI compute capacity, and innovative pill capsule manufacturing.
Key Differentiators
Significant R&D Investment, Therapeutic Specialization and Product Success (e.g., Mounjaro, Zepbound), Strong Intellectual Property, Manufacturing Scale and Capacity, Strategic Partnerships and Alliances, Focus on Innovation and Quality, Digital Transformation and AI Integration.
Clinical Focus
Diabetes and Obesity (Cardiometabolic health), Oncology (Cancer), Immunology, Neuroscience (including neurodegeneration like Alzheimer's disease), Pain.
Target Customers
Patients (directly via LillyDirect), healthcare providers (physicians), pharmacies, hospitals/health systems, and distributors.
Product Stage
Mature
Company Info
- Business Model
- Pharmaceutical development and sales (B2B/B2C hybrid), characterized by extensive R&D, global sales and marketing, strategic partnerships, and direct-to-consumer distribution platforms.
- Founded
- 1876
- Website
- www.lilly.com
Categories
Technologies
Clinical & IP
Clinical Validation
Zepbound FDA-approved Nov 2023. Mounjaro FDA-approved May 2022. Retatrutide Phase 3: 15.3% weight loss, 1.9% HbA1C. Orforglipron FDA priority review Q2 2026.
IP Protection
Strong Intellectual Property
MedStartr Index Score
?What do you think of Eli Lilly?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.